GlassScriptPhysician profile
Richard D Smith
NPI 1528135829
$1,093.40
in general payments reported to CMS, 2019-2025
18 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $266 · 2023: $179 · 2024: $224 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.34 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $148.50 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $137.99 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Astrazeneca Pharmaceuticals LP | $101.09 | 2022-2025 | Imfinzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.37 | 2024 | |
| Agiliti Surgical, INC. | $77.67 | 2023 | Sonablate |
| Sanofi-Aventis U.S. LLC | $75.81 | 2021 | |
| Alexion Pharmaceuticals, INC. | $66.03 | 2022 | |
| Tolmar, INC. | $53.33 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.50 | 2022 | |
| Convatec INC. | $51.13 | 2021 | |
| 180 Medical, INC. | $50.06 | 2021-2022 | |
| Boston Scientific Corporation | $49.18 | 2021-2025 | Spaceoar Vue System - 10ml |
| Gilead Sciences, INC. | $36.08 | 2021 | |
| Endo USA, INC. | $32.81 | 2024-2025 | Aveed, Xiaflex |
| Tolmar Pharmaceuticals, INC. | $23.55 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $21.64 | 2025 | Nucala |
| Teleflex LLC | $20.28 | 2022 | |
| Myriad Genetic Laboratories, INC. | $16.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.